GF Xinde

GF Xinde Investment Management is the private equity and venture capital arm of GF Securities, one of China's leading comprehensive securities firms. Established in 2008, the firm has become a significant player in the healthcare and life sciences sectors, managing multiple funds dedicated to biotechnology, medical devices, and pharmaceutical innovation. GF Xinde focuses on identifying high-growth opportunities across the healthcare value chain, providing capital and strategic resources to both early-stage startups and late-stage enterprises. The firm has a robust track record of investing in prominent Chinese biotech companies and facilitating their paths to initial public offerings. By utilizing the extensive financial network and market expertise of its parent company, GF Xinde supports the commercialization and clinical development of innovative medical technologies within the Asian and global markets.